A significantly higher serum IL-18 level was observed in the COVID-19 patients with MAS than in the patients without MAS (11, 85) and the elevated IL-18 level is associated with disease severity and poor clinical outcome in COVID-19 patients (12, 75). The gene discussed is IL18; the disease is macrophage activation syndrome.